MHRA approves rADAMTS13 (ADZYNMA) for congenital Thrombotic Thrombocytopenic Purpura (cTTP) 

https://www.gov.uk/government/news/mhra-approves-first-uk-treatment-for-congenital-thrombotic-thrombocytopenic-purpura-cttp